Sonio Announces Official Acquisition By Samsung After French Ministry of the Economy and Finance Approval #FrenchFinance

Sonio, the MedTech company specializing in women’s and children’s health, today announces the official approval by the French Ministry of the Economy and Finance of the acquisition of 100% of shares by Samsung.

The deal closes following the company’s second wave of FDA clearance in 2024 and with Sonio reporting and workflow solutions operating in multiple sites across the US.

“Alongside Samsung Medison, we are excited to make significant strides in the maternal care industry. In addition, Sonio plans to continue to advance medical reporting technology and diagnostic software globally, including for underserved areas in healthcare” says Cécile Brosset, Co-Founder and CEO at Sonio.

Established in 2020 to enhance women’s and children’s health globally through medical advancements, and supported by its early investors Elaia, BpiFrance, OneRagtime, Cross Border Impact Ventures, and the EIC Fund, Sonio has developed a reporting and workflow solution powered by AI for obstetrics and gynecology ultrasound that assists clinicians in the evaluation and documentation of ultrasound exams.

Samsung Medison CEO, Kyu Tae Yoo, said, “With the workforce shortages affecting the global healthcare industry, the real-time ultrasound exam guidance and quality assurance developed by Sonio is becoming more relevant to ensure high-quality care. We look forward to combining Sonio’s and Samsung’s advanced engineering to enhance our ultrasound roadmap and introduce next-generation AI technologies to the market. We will focus on innovations designed to enhance exam quality, efficiency, and ultimately improve patient care.”

Sonio will continue its commercial growth independently while developing products and services compatible with all ultrasound device manufacturers. “We are committed to support all healthcare providers and patients as we pursue our mission of providing equal access to high-end technology and quality maternal healthcare globally,” commented Brosset.

About Sonio

Sonio is a highly customizable workflow and practice management solution powered by AI for automation, efficiency, and quality control. Sonio AI-enhanced software empowers ultrasound practitioners and readers. Sonio assists them in performing every prenatal examination to their highest quality standards, ensuring the completeness of each examination, streamlining their workflow, and in prenatal diagnosis. Sonio is based on over five years of research and collaboration between leading experts in fetal medicine and AI.

To learn more about Sonio, visit our website sonio.ai

About Samsung Medison

Samsung Medison is a leading global medical device company, specializing in diagnostic imaging devices. With a mission to bring health and well-being to people’s lives, the company is committed to creating a new future for medical professionals and patients around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating the world’s best IT, image processing, semiconductor and communication technologies into medical devices.

For more information, please visit samsungmedison.com

Originally announced September 2nd, 2024